文献速递眼底病与葡萄膜炎青光眼

Ngn家族转录因子诱导视网膜神经节细胞命运

Retinal Ganglion Cell Fate Induction by Ngn-Family Transcription Factors.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2023-01-01

该研究在小鼠胚胎成纤维细胞中体外过表达Ngn1、Ngn2和Ngn3,并在小鼠幼崽视网膜晚期视网膜祖细胞中体内电转表达Ngn家族转录因子,发现三者均能单独将成纤维细胞重编程为视网膜神经节细胞样神经元,并在体内将晚期视网膜祖细胞重编程为视网膜神经节细胞。

要点

  • Ngn1、Ngn2和Ngn3三种转录因子均能单独在体外将小鼠胚胎成纤维细胞重编程为视网膜神经节细胞样神经元。
  • 重编程细胞在转录组水平类似视网膜神经节细胞,具有典型神经元膜电生理特性,并与视网膜神经元形成功能性突触联系。
  • 在体内,Ngn家族转录因子可将晚期视网膜祖细胞的分化状态重编程以生成视网膜神经节细胞。

核心结论

  • Ngn家族转录因子在体外和体内均能有效诱导视网膜神经节细胞样命运,未来可能进一步探索用于青光眼转化应用。

研究设计与样本

  • 体外实验使用慢病毒将Ngn家族转录因子递送至小鼠胚胎成纤维细胞。
  • 体内实验使用小鼠幼崽视网膜电转将Ngn家族转录因子递送至晚期视网膜祖细胞。
  • 采用免疫荧光染色和RNA测序检测细胞命运重编程,采用膜片钳记录检测神经元电生理功能。

主要发现

  • 体外实验中,Ngn1、Ngn2和Ngn3三种转录因子均能单独将小鼠胚胎成纤维细胞重编程为视网膜神经节细胞样神经元。
  • 重编程细胞在转录组水平类似视网膜神经节细胞,表现出典型神经元膜电生理特性,并与视网膜神经元形成功能性突触联系。
  • 体内实验中,Ngn家族转录因子重编程晚期视网膜祖细胞的分化潜能状态以生成视网膜神经节细胞。

临床怎么用

  • 原文结论指出Ngn家族转录因子未来可能进一步探索用于青光眼转化应用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Retinal ganglion cells (RGCs) are the projection neurons of the retina. Loss of RGCs is the cellular basis for vision loss in patients with glaucoma. Finding ways to regenerate RGCs will aid in the development of regenerative therapies for patients with glaucoma. The aim of this study was to examine the ability of Ngn-family transcription factors (TFs) to induce RGC regeneration through reprogramming in vitro and in vivo. METHODS: In vitro, lentiviruses were used to deliver Ngn-TFs into mouse embryonic fibroblasts (MEFs). In vivo, mouse pup retina electroporation was used to deliver Ngn-TFs into late-stage retinal progenitor cells (RPCs). Immunofluorescence staining and RNA sequencing were used to examine cell fate reprogramming; patch-clamp recording was used to examine neuronal electrophysiologic functions. RESULTS: In vitro, all three Ngn-TFs, Ngn1, Ngn2, and Ngn3, were able to work alone to reprogram MEFs into RGC-like neurons that resembled RGCs at the transcriptome level, exhibited typical neuronal membrane electrophysiologic properties, and formed functional synaptic communications with retinal neurons. In vivo, Ngn-TFs reprogrammed the differentiation-competent state of late-stage RPCs to generate RGCs. CONCLUSIONS: Ngn-TFs are effective in inducing an RGC-like fate both in vitro and in vivo and might be explored further in the future for glaucoma translational applications.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Zhang K, Cai W, Xin Y, et al. Retinal Ganglion Cell Fate Induction by Ngn-Family Transcription Factors. Invest Ophthalmol Vis Sci. 2023. PMID: 38133504. doi:10.1167/iovs.64.15.32

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。